These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2535112)

  • 1. Beta-2 microglobulin amyloidosis in a patient on long-term continuous ambulatory peritoneal dialysis (CAPD).
    Colombi A; Wegmann W
    Perit Dial Int; 1989; 9(4):321-4. PubMed ID: 2535112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta 2-microglobulin amyloidosis in a patient treated exclusively by continuous ambulatory peritoneal dialysis.
    Jadoul M; Noel H; van Ypersele de Strihou C
    Am J Kidney Dis; 1990 Jan; 15(1):86-8. PubMed ID: 2403753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta2-microglobulin amyloidosis in hemodialysis and peritoneal dialysis patients.
    Dervisoglu E; Anik Y; Erdogan S; Akansel G; Yilmaz A
    Ther Apher Dial; 2008 Aug; 12(4):306-10. PubMed ID: 18789118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum beta 2-microglobulin concentration in dialysis patients: importance of intrinsic renal function.
    McCarthy JT; Williams AW; Johnson WJ
    J Lab Clin Med; 1994 Apr; 123(4):495-505. PubMed ID: 8144998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-2 microglobulin in patients on peritoneal dialysis and hemodialysis.
    Scalamogna A; Imbasciati E; De Vecchi A; Castelnovo C; Pagliari B; De Cristofaro V; Ponticelli C
    Perit Dial Int; 1989; 9(1):37-40. PubMed ID: 2488178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical, radiological and serum amyloid P component scintigraphic features of beta2-microglobulin amyloidosis associated with continuous ambulatory peritoneal dialysis.
    Tan SY; Baillod R; Brown E; Farrington K; Soper C; Percy M; Clutterbuck E; Madhoo S; Pepys MB; Hawkins PN
    Nephrol Dial Transplant; 1999 Jun; 14(6):1467-71. PubMed ID: 10383009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations of synovial tissue and their potential role in the deposition of beta2-microglobulin-associated amyloid.
    Ehlerding G; Schaeffer J; Drommer W; Miyata T; Koch KM; Floege J
    Nephrol Dial Transplant; 1998 Jun; 13(6):1465-75. PubMed ID: 9641177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of histological beta2-microglobulin amyloidosis in CAPD patients compared with hemodialysis patients.
    Jadoul M; Garbar C; Vanholder R; Sennesael J; Michel C; Robert A; Noël H; van Ypersele de Strihou C
    Kidney Int; 1998 Sep; 54(3):956-9. PubMed ID: 9734623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose.
    Heimbürger O; Stenvinkel P; Berglund L; Tranoeus A; Lindholm B
    Nephron; 1996; 72(2):135-44. PubMed ID: 8684516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histological characteristics of sternoclavicular beta 2-microglobulin amyloidosis and clues for its histogenesis.
    Garbar C; Jadoul M; Noël H; van Ypersele de Strihou C
    Kidney Int; 1999 May; 55(5):1983-90. PubMed ID: 10231463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-2 microglobulin removal during continuous ambulatory peritoneal dialysis (CAPD).
    Lysaght MJ; Pollock CA; Moran JE; Ibels LS; Farrell PC
    Perit Dial Int; 1989; 9(1):29-35. PubMed ID: 2488177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sclerosing peritonitis in continuous ambulatory peritoneal dialysis patients: one center's experience and review of the literature.
    Afthentopoulos IE; Passadakis P; Oreopoulos DG; Bargman J
    Adv Ren Replace Ther; 1998 Jul; 5(3):157-67. PubMed ID: 9686626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morbidity and mortality of CAPD and hemodialysis.
    Maiorca R; Cancarini GC; Brunori G; Camerini C; Manili L
    Kidney Int Suppl; 1993 Feb; 40():S4-15. PubMed ID: 8445838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Destructive spondyloarthropathy in a patient on continuous ambulatory peritoneal dialysis for 13 years.
    Digenis GE; Davidson G; Dombros NV; Katz A; Bookman A; Oreopoulos DG
    Perit Dial Int; 1993; 13(3):228-31. PubMed ID: 8369355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta 2-microglobulin elimination in end-stage renal disease patients on renal replacement therapy.
    Stefanović V; Kostić S; Djordjević V; Mitić M; Bogicević M
    Perit Dial Int; 1993; 13 Suppl 2():S520-2. PubMed ID: 8399654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dialysis amyloidosis syndrome in patients aged over 55 years and undergoing a hemodialysis program].
    Il'in AP; Bogoiavlenskiĭ VF; Gazizov RM; Stepanov PV
    Klin Lab Diagn; 2003 Feb; (2):37-40. PubMed ID: 12688213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous ambulatory peritoneal dialysis vs haemodialysis: a lesser risk of amyloidosis?
    Tielemans C; Dratwa M; Bergmann P; Goldman M; Flamion B; Collart F; Wens R
    Nephrol Dial Transplant; 1988; 3(3):291-4. PubMed ID: 3140103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal changes of peritoneal function calculated by personal dialysis capacity in a patient after long-term continuous ambulatory peritoneal dialysis.
    Nakamoto H; Takane H; Sugahara S; Kanno Y; Okada H; Yamamoto T; Suzuki H
    Adv Perit Dial; 2003; 19():97-102. PubMed ID: 14763042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta 2-microglobulin levels in patients with renal insufficiency.
    Acchiardo S; Kraus AP; Jennings BR
    Am J Kidney Dis; 1989 Jan; 13(1):70-4. PubMed ID: 2643313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dialysis amyloidosis: current disease concepts and new perspectives for its treatment.
    Gejyo F; Arakawa M
    Contrib Nephrol; 1990; 78():47-59; discussion 59-60. PubMed ID: 2225843
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.